<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Repligen from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Repligen news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 09:06:45 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Repligen" rel="self" type="application/rss+xml" />

	
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026075&amp;HITNO=0&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026075&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2530335377%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4026075&amp;HITNO=0&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4026075&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2530335377%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018040&amp;HITNO=1&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018040&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525445888%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018040&amp;HITNO=1&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018040&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525445888%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Repligen receives USPTO Notice of Allowance for patent covering a recombinant form of Protein A</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010606&amp;HITNO=2&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010606&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522536338%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4010606&amp;HITNO=2&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4010606&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522536338%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013289&amp;HITNO=3&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013289&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523676048%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013289&amp;HITNO=3&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013289&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523676048%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Freshnews.com:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013031&amp;HITNO=4&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013031&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523589254%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013031&amp;HITNO=4&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013031&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523589254%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017286&amp;HITNO=5&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017286&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525069081%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4017286&amp;HITNO=5&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4017286&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525069081%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Boston Globe:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016519&amp;HITNO=6&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016519&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524786513%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4016519&amp;HITNO=6&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4016519&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2524786513%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013924&amp;HITNO=7&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013924&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523855622%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013924&amp;HITNO=7&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013924&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523855622%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013584&amp;HITNO=8&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013584&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523767436%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013584&amp;HITNO=8&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013584&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523767436%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Phoenix Business Journal:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013112&amp;HITNO=9&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013112&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523614363%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4013112&amp;HITNO=9&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4013112&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523614363%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4012872&amp;HITNO=10&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4012872&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523545296%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4012872&amp;HITNO=10&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4012872&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523545296%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>NewsBlaze:</description></item>
<item><title>Repligen Reports Third Quarter Fiscal Year 2010 Financial Results</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4012865&amp;HITNO=11&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4012865&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523544299%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4012865&amp;HITNO=11&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4012865&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523544299%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Sys-Con Media:</description></item>
<item><title>Repligen Receives Notice of Allowance for Recombinant Protein A Patent</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4011956&amp;HITNO=12&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4011956&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523174485%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4011956&amp;HITNO=12&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4011956&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523174485%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MDLinx:</description></item>
<item><title>Repligen Receives Notice of Allowance for Recombinant Protein A Patent</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4005331&amp;HITNO=13&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4005331&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520325337%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4005331&amp;HITNO=13&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4005331&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520325337%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Repligen Receives Notice of Allowance for Recombinant Protein A Patent</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4006055&amp;HITNO=14&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4006055&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520570517%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4006055&amp;HITNO=14&amp;MSIZE=29&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Repligen&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4006055&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520570517%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
</channel></rss>